SafeStitch Medical Changes Name to TransEnterix, Inc.
09 Diciembre 2013 - 6:00AM
Business Wire
Company to trade under new ticker symbol
TRXC
SafeStitch Medical, Inc. (OTCBB:SFES) (OTCBB:TRXC), which
recently merged with TransEnterix, Inc., announced the company’s
name has been changed to TransEnterix, Inc. following actions
previously taken by its Board of Directors and a majority of its
stockholders. The company will begin trading on the OTC Bulletin
Board (“OTCBB”) under the new ticker symbol “TRXC,” effective
December 9, 2013. The new ticker symbol replaces “SFES” and
reflects the combined company’s new name. These changes do not
otherwise affect shares of common stock held by the company’s
stockholders.
“Today’s announcement represents a significant milestone
following our merger with SafeStitch Medical. The combined company
is poised to deliver innovative new
products for minimally invasive surgery, including
the SurgiBotTM, a patient-side minimally invasive surgical
robotic system,” said Todd M. Pope, president and CEO of
TransEnterix.
About TransEnterix
TransEnterix is a development-stage medical device company that
is pioneering the use of flexible instruments and robotics to
improve how minimally invasive surgery is performed. The company is
focused on the development and commercialization of SurgiBot, a
patient-side minimally invasive surgical robotic system. For more
information, visit the company website
at www.transenterix.com.
This press release contains “forward-looking statements,” as
that term is defined under the Private Securities Litigation Reform
Act of 1995 (PSLRA), which statements may be identified by words
such as “expects,” “plans,” “projects,” “will,” “may,”
“anticipate,” “believes,” “should,” “intends,” “estimates,” and
other words of similar meaning, including statements regarding our
product development and commercialization efforts and benefits of
combining TransEnterix and SafeStitch Medical. Many factors,
including those described herein and in our filings with the
Securities and Exchange Commission, could cause our actual
activities or results to differ materially from the activities and
results anticipated in forward-looking statements. These factors
include, but are not limited to: whether the name change and change
in ticker symbol will be a significant milestone and whether the
company is poised to deliver innovative new products for minimally
invasive surgery, including the SurgiBot. The forward-looking
statements contained in this press release speak only as of the
date the statements were made, and we do not undertake any
obligation to update forward-looking statements, except as required
under applicable law. We intend that all forward-looking statements
be subject to the safe-harbor provisions of the PSLRA.
Westwicke PartnersMark Klausner,
443-213-0501transenterix@westwicke.com
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024